Atomera Incorporated vs Smith & Nephew plc — how do they compare? Atomera Incorporated trades at $5.66 (market cap $217.36M), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 57.7× Atomera Incorporated's market cap, and Smith & Nephew plc pays a 2.65% dividend while Atomera Incorporated pays none. Which is the better fit depends on your goals.
| ATOM | SNN | |
|---|---|---|
Market Cap | $217.36M | $12.54B |
Sector | Technology | Health |
52-Week High | $12.11 | $38.70 |
52-Week Low | $1.99 | $28.73 |
Enterprise Value | $180.18M | $15.57B |
Dividend Yield | — | 2.65% |
Trailing returns across standard periods
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →